Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53–MDM2 Interaction Useful in Targeted Cancer Therapy

被引：0
|
作者：
Alpana K. Gupta
Mausumi Bharadwaj
Anoop Kumar
Ravi Mehrotra
机构：
[1] National Institute of Cancer Prevention and Research (ICMR),Division of Molecular Cytology, Department of Health Research (Govt. of India)
[2] National Institute of Cancer Prevention and Research (ICMR),Division of Molecular Genetics and Biochemistry
来源：
Topics in Current Chemistry | 2017年 / 375卷
关键词：
p53–MDM2 interaction; Small molecule inhibitors; Spiro-oxindoles; Anticancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [22] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [23] Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
    Shen, Hong
    Maki, Carl G.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (06) : 560 - 568
  • [24] New chemical tools for disrupting the MDM2/p53 protein-protein interaction: Identification, synthesis and biological evaluation of a novel class of MDM2/p53 inhibitors
    Pernazza, Daniele
    Li, Xiaolong
    Lawrence, Harshani R.
    Guida, Wayne C.
    DuBoulay, Courtney J.
    Watts, Shawn
    Sebti, Sayd M.
    Chen, Jiandong
    Lawrence, Nicholas J.
    CANCER RESEARCH, 2011, 71
  • [25] The p53 and Mdm2 families in cancer
    Michael, D
    Oren, M
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) : 53 - 59
  • [26] Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Zhu, Haohao
    Gao, Hui
    Ji, Yingying
    Zhou, Qin
    Du, Zhiqiang
    Tian, Lin
    Jiang, Ying
    Yao, Kun
    Zhou, Zhenhe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [27] Targeted Molecular Therapy for Neuroblastoma: The ARF/MDM2/p53 Axis
    Kim, Eugene
    Shohet, Jason
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (22): : 1527 - 1529
  • [28] On the biosynthesis of an inhibitor of the p53/MDM2 interaction
    Duncan, SJ
    Williams, DH
    Ainsworth, M
    Martin, S
    Ford, R
    Wrigley, SK
    TETRAHEDRON LETTERS, 2002, 43 (06) : 1075 - 1078
  • [29] Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors
    Ivanenkov, Yan A.
    Vasilevski, Sergei V.
    Beloglazkina, Elena K.
    Kukushkin, Maksim E.
    Machulkin, Alexey E.
    Veselov, Mark S.
    Chufarova, Nina V.
    Chernyaginab, Elizaveta S.
    Vanzcool, Anton S.
    Zyk, Nikolay V.
    Skvortsov, Dmitry A.
    Khutornenko, Anastasia A.
    Rusanov, Alexander L.
    Tonevitsky, Alexander G.
    Dontsova, Olga A.
    Majouga, Alexander G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (02) : 404 - 409
  • [30] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
    Shangary, Sanjeev
    Wang, Shaomeng
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 223 - 241
12345